39 completed, 17 unknown, 3 terminated, 1 not yet recruiting. 60 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 60 | Completed 39, Unknown 17, Terminated 3, Not yet recruiting 1 |
Follow Colonic Diseases, Functional: new trials by email Literature Review of Colonic Diseases, Functional trials Research Report on Colonic Diseases, Functional
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "Efficacy and Safety of Linaclotide in Chronic Constipation" Linaclotide 72 micrograms, Linaclotide 145 micrograms, Placebo - Chronic Idiopathic Constipation, Irritable Bowel Syndrome (IBS-C) | Phase 4 | Not yet recruiting | Md Mehedi Shahriar | 90 | 2026-02-20 | 2026-02-25 |
| Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome Skal Pro, Placebo - Irritable Bowel Syndrome, Gastrointestinal Diseases | Phase 4 | Completed | EP Plus Group Sdn Bhd | 57 | 2024-10-17 | 2026-09-11 |
| The Effects of Probiotics, Lactobacillus GG, in the Treatment of Abdominal Pain in Children With Functional Abdominal Pain Disorders LGG, Placebo - Functional Abdominal Pain Syndrome | Phase 4 | Unknown | Prince of Songkla University | 54 | 2024-03-21 | 2024-03-18 |
| Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation Tenapanor - IBS, IBS - Irritable Bowel Syndrome | Phase 4 | Completed | Kyle Staller, MD, MPH | 36 | 2024-02-06 | 2026-03-12 |
| Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS DAO supplement, Placebo - Irritable Bowel Syndrome (IBS) | Phase 4 | Unknown | Nanjing First Hospital, Nanjing Medical University | 150 | 2023-11-01 | 2023-11-18 |
| To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea Rifaximin 550 MG, Mebeverine 135 MG, Psyllium Husk - Irritable Bowel Syndrome With Diarrhea | Phase 4 | Completed | Bahria University | 162 | 2023-01-03 | 2023-07-27 |
| Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D) Probiotic formulation, Placebo - IBS - Irritable Bowel Syndrome | Phase 4 | Unknown | Lallemand Health Solutions | 162 | 2022-08-11 | 2024-02-20 |
| Colonoscopic Probiotics Infusion for Functional Gastrointestinal Disease Live Combined Bifidobacterium and Lactobacillus, Normal saline, Basic treatment - Functional Constipation, Irritable Bowel Syndrome | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 160 | 2022-07-04 | 2022-08-04 |
| Neostigmine Route for Acute Colonic Pseudo Obstruction Neostigmine - Ogilvie Syndrome | Phase 4 | Unknown | University of Southern California | 90 | 2022-02-04 | 2023-08-25 |
| Postinfectious Irritable Bowel Syndrome and Gelsectan (Gelsectan, Devintec Sagl) - Irritable Bowel Syndrome | Phase 4 | Completed | Evangelismos Hospital | 275 | 2021-09-01 | 2024-02-28 |
| Rifaximin Therapy vs Low FODMAP Diet In IBS Rifaximin, Low FODMAP diet - Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth | Phase 4 | Unknown | University of Malaya | 100 | 2021-04-22 | 2023-05-16 |
| Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders Linaclotide, Lactulose, Omeprazol - Functional Dyspepsia, Constipation-predominant Irritable Bowel Syndrome | Phase 4 | Unknown | RenJi Hospital | 78 | 2021-01-01 | 2021-12-13 |
| Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas Iberogast® and Iberogast® N - Irritable Bowel Syndrome, Functional Dyspepsia | Phase 4 | Completed | Hospital Vall d'Hebron | 68 | 2020-09-03 | 2023-09-22 |
| Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study Triple therapy for H.pylori - Irritable Bowel Syndrome | Phase 4 | Unknown | Assiut University | 100 | 2020-08-10 | 2020-08-14 |
| Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D Rifaximin, Probiotic Formula, Placebo oral tablet - IBS - Irritable Bowel Syndrome, Gut Microbiota | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 240 | 2020-05-10 | 2020-07-28 |
| Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea Rifaximin, Glucose and lactulose hydrogen breath testing - Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea | Phase 4 | Completed | University of Michigan | 148 | 2020-01-09 | 2026-01-12 |
| Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico I31 probiotic, I31 probiotic combined to Alverine/Simethicone, Placebo - Irritable Bowel Syndrome | Phase 4 | Completed | Hospital Juarez de Mexico | 55 | 2018-09-03 | 2020-01-23 |
| The DOMINO Trial: Diet Or Medication in Irritable Bowel syNdrOme IBS Diet, Otilonium Bromide - Irritable Bowel Syndrome | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 472 | 2018-07-26 | 2020-11-17 |
| A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing Rifaximin 550 MG, Low FODMAP Diet - Irritable Bowel Syndrome | Phase 4 | Completed | University of Michigan | 74 | 2018-02-13 | 2025-04-27 |
| Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth Saccharomyces Boulardii 250 MG, Dietary advice following a low fermentation diet - Irritable Bowel Syndrome | Phase 4 | Completed | Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | 71 | 2017-02-01 | 2020-11-13 |
Showing 20 of 60. Sign in to see all of them.
Irritable Bowel Syndrome (58) · Diarrhea (6) · Abdominal Pain (4) · Colonic Diseases (3) · Colitis, Ulcerative (2) · Constipation (2) · Depressive Disorder, Major (2) · Digestive System Diseases (2) · Flatulence (2) · Gastrointestinal Diseases (2) · Colonic Pseudo-Obstruction (1) · Cystitis, Interstitial (1) · Depression (1) · Disease (1)
Intestinal Diseases (59) · Digestive System Diseases (58) · Gastrointestinal Diseases (58) · Colonic Diseases (57) · Pathological Conditions, Signs and Symptoms (13) · Signs and Symptoms (12) · Signs and Symptoms, Digestive (11) · Neurologic Manifestations (5) · Mental Disorders (4) · Pain (4) · Anxiety Disorders (2) · Colitis (2) · Depressive Disorder (2) · Gastroenteritis (2)
Rifaximin (5) · Duloxetine Hydrochloride (3) · FODMAP Diet (3) · Probiotics (3) · Simethicone (3) · Escitalopram (2) · Lacteol (2) · Sugars (2) · alverine (2) · ebastine (2) · mebeverine (2) · octylonium (2) · ramosetron (2) · (1-6)-alpha-glucomannan (1) · Amitriptyline (1)
Astellas Pharma Inc (2) · KU Leuven (2) · Laboratoires Mayoly Spindler (2) · Shandong University (2) · University of Michigan (2) · Aga Khan University (1) · American Academy of Family Physicians (1) · Asian Institute of Gastroenterology, India (1) · Assiut University (1) · Azienda Policlinico Umberto I (1) · Bahria University (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Bukwang Pharmaceutical (1) · Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (1) · Chinese University of Hong Kong (1)
United States (13) · China (6) · Italy (4) · Belgium (3) · Pakistan (3) · United Kingdom (3) · Japan (2) · Malaysia (2) · Netherlands (2) · Poland (2) · South Korea (2) · Spain (2) · Argentina (1) · Bangladesh (1) · Greece (1)
Guy Boeckxstaens, M.D. (2) · Abdullah Aljahdali, MD (1) · Abed Allehibi, Dr (1) · Alicia J Kaplan, MD (1) · Allen Lee, MD (1) · Andrea Horvath, MD (1) · Anna H Lyra, PhD (1) · Arthur C Ouwehand, PhD (1) · Ashton Harper, MRCS (1) · Ashwin A Patkar, M.D. (1) · Brian P Brennan, MD (1) · Cheryl Stevenson, M.Sc (1) · Dr. Nageshwar Reddy, DM (1) · Dr. Nitesh Pratap, DM (1)
PMID 19158975, PMID 19548294, PMID 21087463, PMID 23602047, PMID 23716985, PMID 23980534, PMID 24063420, PMID 24147869, PMID 26396720, PMID 26752109, PMID 27306945, PMID 27490103, PMID 28293280, PMID 28331539, PMID 29801486, PMID 31677711, PMID 33038815, PMID 35483886, PMID 38191268, PMID 39086991, PMID 40079184, PMID 41098003, PMID 41436948, PMID 42025708, PMID 42609157, PMID 42663160
2009 (1), K23DK124567 (1), UL1RR024150 (1)